combretastatin has been researched along with Necrosis in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bertelsen, LB; Bohn, AB; Brems-Eskildsen, AS; Horsman, MR; Laurberg, T; Møller, BK; Nielsen, T; Stødkilde-Jørgensen, H; Wittenborn, T | 1 |
| Burchill, SA; Dalal, S | 1 |
| Hori, K | 1 |
| Breidahl, T; Horsman, MR; Maxwell, RJ; Nielsen, FU; Stødkilde-Jørgensen, H | 1 |
1 review(s) available for combretastatin and Necrosis
| Article | Year |
|---|---|
Starvation tactics for solid tumors: tumor blood flow interruption via a combretastatin derivative (Cderiv), and its microcirculation mechanism.
Topics: Animals; Antineoplastic Agents, Phytogenic; Bibenzyls; Humans; Microcirculation; Necrosis; Neoplasms | 2012 |
3 other study(ies) available for combretastatin and Necrosis
| Article | Year |
|---|---|
A combretastatin-mediated decrease in neutrophil concentration in peripheral blood and the impact on the anti-tumor activity of this drug in two different murine tumor models.
Topics: Animals; Bibenzyls; Carcinoma, Squamous Cell; Disease Models, Animal; Female; Flow Cytometry; Granulocytes; Humans; Mammary Neoplasms, Animal; Mice; Necrosis; Neovascularization, Pathologic; Neutrophils | 2014 |
Preclinical evaluation of vascular-disrupting agents in Ewing's sarcoma family of tumours.
Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Bibenzyls; Bone Neoplasms; Cell Proliferation; Diphosphates; Disease Models, Animal; Doxorubicin; Drug Evaluation, Preclinical; Mice; Mice, Nude; Necrosis; Neoplasm Transplantation; Neovascularization, Pathologic; Sarcoma, Ewing; Stilbenes | 2009 |
Effects of combretastatin on murine tumours monitored by 31P MRS, 1H MRS and 1H MRI.
Topics: Animals; Antineoplastic Agents, Phytogenic; Bibenzyls; Drug Screening Assays, Antitumor; Energy Metabolism; Hydrogen; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Mammary Neoplasms, Animal; Mice; Necrosis; Phosphorus; Stilbenes | 1998 |